Introduction
Lysosomal acid lipase (LAL) deficiency (LALD) is a multisystemic autosomal recessive storage disease caused by mutations in the LIPA (OMIM #278000) 1 . LALD leads to an accumulation of cholesteryl esters and triglycerides in the lysosomes of the liver, spleen, and cardiovascular system and patients develop progressive liver dysfunction as well as cardiovascular disease. LALD presents as two major clinical phenotypes: infantile-onset Wolman disease (WD) and later-onset cholesteryl ester storage disease (CESD). WD is a rare, neonatal-onset, fulminant subtype marked by decreased LAL activity that results in massive lysosomal accumulation of cholesteryl esters and triglycerides, predominantly in the liver, spleen, adrenal glands, bone marrow, lymph nodes, and macrophages.
The symptoms in infants with WD include vomiting, diarrhea, and massive hepatosplenomegaly with adrenal calcifications evident by two to four months of age 2 . In contrast, CESD is a later-onset subtype, often unrecognized, although present in infancy, childhood or adulthood, depending on residual in vitro LAL activity 1 
Case 2
The youngest sister of the patient described in Case 1 was admitted to our hospital when she was one month old with marked abdominal distention. Extensive hepa- crosis (Fig. 2d) . Information was not obtained from mutational analysis of the LIPA gene due to poor quality of extracted DNA. (Table 1 ) Surprisingly, reported cases of patients with WD or CESD are extremely rare in Japan 2 30 . Only 14 cases of patients with WD and seven cases of CESD have been officially reported 2 30 , including publications in the Japanese 
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Discussion
Here, we report two babies with WD (Fig. 3) . Recently, the drug for enzyme replacement therapy against LALD has been approved and is available in Japan. Thus, WD A literature review of LALD cases showed that they were extremely rare in Japan 2 30 . The reason for their rarity is unknown, although it could be due to racial diversity. A lack of awareness about LALD may also be a reason. Because LALD is now treatable, we are actively vigilant for patients with LALD.
In conclusion, it is necessary to increase awareness about LALD to pediatricians and doctors of internal medicine in order to detect and treat patients with LALD.
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